Innovation is a hot topic in Europe. But how can its potential be used to the fullest, and what are the challenges in doing that?
The Europe Lab aims to support the design, launch and implementation of actionable agendas for public-private collaborations to increase competitiveness and inclusive growth in Europe.
Pathological microbes are increasingly resistant to antimicrobial treatments. The resulting health crisis is one of the greatest challenges facing society. At this event, Jim O'Neill will present the Independent Review on Antimicrobial Resistance and a panel will discuss how to tackle drug resistance.
We were pleased to welcome Paul Misener, Vice President of Global Public Policy at Amazon.com, to discuss innovation and regulation.
The OECD has been pushing the idea that the productivity slowdown is not so much due to a lack of innovation but rather due to a lack of innovation diffusion between firms.
There were high expectations for the effect of the COMPETES Acts on the US research and innovation landscape. But were these expectations met and what can Europea learn from the US experience?
This Policy Contribution examines the EU’s struggle to improve its capacity for innovation, in particular the differences between EU member states in terms of their capacity to innovate.
The green agenda is a top priority of the Juncker commission. In this event we will focus the role of competition policy in promoting sustainability and green innovation.
Making the manufacturing sector more competitive is vital to restore economic growth in Europe. Changing business models to sell services as well as products can provide useful revenue to manufacturers.
The long-term impact of migration on innovation and productivity growth in host countries is a neglected issue in the current debate on refugees. Research shows that these effects can be substantial, but if Europe wants to capitalize on this potential it will need better information systems to match migrants’ skill sets with host environments.
Near universal access to quality healthcare is an emblem of the "European model", but how can we ensure the sustainability of EU healthcare systems in an era of aging populations and budget restraint? Do innovation and more effective measurement of outcomes offer a way forward?
Europe has lofty ambitions for building a socially and environmentally sustainable future on the basis of growth and prosperity through innovation. Despite these policies and pronouncements, Europe’s performance on innovation remains weak. In this context, Rienhilde Veugelers assesses whether the deployment of innovation policy instruments in EU countries matches their innovation capacity performance relative to other EU countries.